S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
3 Key Stocks Helping to Drive the EV Race
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
NASDAQ:SNSE

Sensei Biotherapeutics (SNSE) Stock Price, News & Analysis

$1.05
-0.04 (-3.67%)
(As of 04/12/2024 ET)
Today's Range
$1.05
$1.11
50-Day Range
$0.76
$1.17
52-Week Range
$0.51
$1.93
Volume
31,892 shs
Average Volume
66,752 shs
Market Capitalization
$26.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Sensei Biotherapeutics MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
281.0% Upside
$4.00 Price Target
Short Interest
Healthy
0.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.38
Upright™ Environmental Score
News Sentiment
0.62mentions of Sensei Biotherapeutics in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.97) to ($0.87) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.38 out of 5 stars

Medical Sector

118th out of 921 stocks

Pharmaceutical Preparations Industry

42nd out of 418 stocks

SNSE stock logo

About Sensei Biotherapeutics Stock (NASDAQ:SNSE)

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors. It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.

SNSE Stock Price History

SNSE Stock News Headlines

Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price Down 1.8%
Buy Alert: Get these AI trades on repeat
With this AI Trade Finder, one of my newer students took his trading account from $1,500 to over $9,400 in just over a month
Sensei Biotherapeutics CFO Erin Colgan to resign
Buy Alert: Get these AI trades on repeat
With this AI Trade Finder, one of my newer students took his trading account from $1,500 to over $9,400 in just over a month
Sensei Biotherapeutics to Present at Upcoming Conferences
See More Headlines
Receive SNSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensei Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2024
Today
4/12/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SNSE
Fax
N/A
Employees
28
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.00
High Stock Price Target
$4.00
Low Stock Price Target
$4.00
Potential Upside/Downside
+281.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-34,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$2.60 per share

Miscellaneous

Free Float
18,678,000
Market Cap
$26.32 million
Optionable
Not Optionable
Beta
0.17
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. John K. Celebi M.B.A. (Age 52)
    President, CEO & Director
    Comp: $799.69k
  • Ms. Erin Colgan (Age 43)
    Chief Financial Officer
    Comp: $558.83k
  • Dr. Edward Van der Horst Ph.D. (Age 51)
    Chief Scientific Officer
    Comp: $444.87k
  • Ms. Lora Pike
    Vice President of Investor Relations & Communications
  • Mr. Christopher W. Gerry J.D.
    Senior VP, General Counsel & Secretary
  • Ms. Stephanie Krebs M.B.A.
    M.S., Chief Business Officer
  • Dr. Aaron Weitzman FACP
    M.D., Ph.D., Chief Medical Officer

SNSE Stock Analysis - Frequently Asked Questions

Should I buy or sell Sensei Biotherapeutics stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sensei Biotherapeutics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" SNSE shares.
View SNSE analyst ratings
or view top-rated stocks.

What is Sensei Biotherapeutics' stock price target for 2024?

1 equities research analysts have issued twelve-month price targets for Sensei Biotherapeutics' shares. Their SNSE share price targets range from $4.00 to $4.00. On average, they expect the company's share price to reach $4.00 in the next year. This suggests a possible upside of 281.0% from the stock's current price.
View analysts price targets for SNSE
or view top-rated stocks among Wall Street analysts.

How have SNSE shares performed in 2024?

Sensei Biotherapeutics' stock was trading at $0.6920 on January 1st, 2024. Since then, SNSE shares have increased by 51.7% and is now trading at $1.05.
View the best growth stocks for 2024 here
.

When is Sensei Biotherapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our SNSE earnings forecast
.

How were Sensei Biotherapeutics' earnings last quarter?

Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) issued its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.30) earnings per share for the quarter, beating analysts' consensus estimates of ($0.32) by $0.02.

When did Sensei Biotherapeutics IPO?

Sensei Biotherapeutics (SNSE) raised $100 million in an initial public offering on Friday, February 5th 2021. The company issued 5,900,000 shares at $16.00-$18.00 per share. Citigroup, Piper Sandler, Berenberg and Oppenheimer & Co. acted as the underwriters for the IPO.

How do I buy shares of Sensei Biotherapeutics?

Shares of SNSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SNSE) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners